1 hour Ago
Obesity's Hidden Links to Other Diseases
Medical experts point out that obesity is already tied to 13 different types of cancer, along with heart disease and joint problems. In these cases, losing weight isn't just a cosmetic win; it's genuinely seen as one of the main ways to cut disease risk.
Liesbeth van Rossum, an internist-endocrinologist who specializes in obesity, explained that medicine has long focused on treating the conditions that obesity causes rather than obesity itself. "Now an era is coming in which we can increasingly treat obesity itself, which lies as the driving factor behind those diseases," she said.
But the story doesn't end with weight loss alone. Scientists are digging into whether these drugs might work directly on the body in ways separate from shedding fat. Van Rossum mentioned there are early signs that the medications could benefit blood vessels directly, which would matter a lot for people at risk of cardiovascular disease. Still, she was quick to add a note of caution, saying much of the current evidence comes from smaller studies or indirect data, so solid proof is still a work in progress in many areas.
Inflammation and HIV: A Promising but Early Discovery
One of the more exciting areas researchers are watching closely is inflammation. Casper Rokx, an internist and HIV specialist who treats patients dealing with both HIV and obesity, has seen encouraging results firsthand. "The drugs also work fantastically against inflammatory responses. That is exactly something people with HIV, on average, suffer from a lot," he explained, adding that the implications for HIV treatment could be significant.
Chronic inflammation has long been one of the toughest parts of managing HIV, and according to Rokx, there simply haven't been many effective options to address it directly until now.
Another example comes from Modini Kakade, who lives with sarcoidosis, a disease that causes inflammation in the body's organs and tissues. After trying a weight-loss drug that she got through her husband, originally meant purely for weight loss, she reportedly saw her symptoms vanish entirely.
Even so, Rokx isn't ready to call it a breakthrough just yet. He believes more solid, controlled research is necessary before these drugs get used more widely for inflammation tied to HIV, especially in people who aren't overweight. "I would like that in a research setting. Then you can investigate whether you can already reduce that inflammatory response before people are overweight, and whether that also leads to better survival," he said.
Van Rossum, meanwhile, made it clear that no matter how promising the early results look, these drugs should never be taken without medical guidance. "I would strongly urge that people not simply start using them on their own," she cautioned.
